The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study
Diabetes Res Clin Pract. 2025 Mar 31:112119. doi: 10.1016/j.diabres.2025.112119. Online ahead of print.ABSTRACTAIM: The STOP study is a proof-of-concept, aimed at evaluating the effectiveness and safety of IdegLira in deintensifying diabetes therapy in elderly insulin-treated persons with T2DM.METHO